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This paper describes a case of secondary recurrent internal carotid artery stenosis after angioplasty and stenting which
required surgical intervention. A 72-year old women presented one year after a standard internal carotid artery
endarterectomy with an asymptomatic restenosis that was treated with angioplasty and stenting. Six months later the
patient presented with a 90% ipsilateral secondary recurrent stenosis that was treated surgically with stent removal and vein
patch angioplasty.
Ipsilateral secondary recurrent internal carotid artery restenosis is a rare occurrence especially after endovascular treatment.
We believe that prophylactic surgical treatment could be a good and safe option for stenoses of more than 80%.
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Introduction
Carotid restenosis is one of the major factors limiting
long term patency following carotid endarterectomy
(CEA). The indication and surgical management of
restenosis is controversial due to the high compli-
cation rate. Recently, endovascular treatment (percu-
taneous transluminal angioplasty (PTA) and stenting)
has been proposed as an alternative to conventional
surgery. Few currentstudies support the routine use of
this technique.
We report a case of internal carotid artery (ICA)
restenosis after CEA treated with PTA and stenting
that developed a secondary recurrent stenosis which
required surgical intervention.
Case report
A 72 year old women was initially admitted with a one
month history of dizziness. The duplex scan showed a
90% right ICA stenosis and no significant left ICA or
vertebral arteries stenoses. The brain CT scan showed
no ischaemic or haemorrhagic lesions. The patient
went on to have a standard right CEA without patch
insertion. The postoperative period was uneventuful
and the patient was discharged four days postopera-
tively on ticlopidine. At six months follow-up the
patient was asymptomatic and the right ICA was
patent at duplex scan.
One year after the first surgical operation she was
still asymptomatic but the duplex scan showed an 80%
ICA restenosis confirmed on DSA (Figure 1) at the
endarterectomy site. Brain CT scan was normal and
she proceeded to endovascular treatment. A balloon
angioplasty with stenting (Palmaz) was performed
through the left common femoral artery. An excellent
immediate radiological result was documented by
intra-arterial digital subtraction angiography (IA-
DSA) (Figure 2) and duplex scanning. The post-
intervention course was uneventful and the patient
was discharged after two days on ticlopidine.
Six months after the endovascular procedure the
patient was still asymptomatic but the duplex scan
showed a 90% stenosis of the right ICA at the proximal
and distal ends of the carotid stent and not at the level
of the stent body. The lesion was subsequently treated
surgically with stent removal and vein patch angio-
plasty (Figure 3) because of extensive neointimal
hyperplasia.
The post-operative course was uneventful and the
patient was discharged after seven days on ticlopidine.
At one year follow-up at duplex scan she remains well.
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Discussion
The NASCET1 and ECST2 trials have shown the
effectiveness of CEA for symptomatic ICA stenoses
greater than70%. The same effectiveness has not been
statistically demonstrated for the asymptomatic ICA
stenosis.
Among the several clinical trials on the treatment of
the asymptomatic ICA stenosis only the Asympto-
matic Carotid Atherosclerosis Study (ACAS) 3 has has
produced a firm conclusion.
In 1996 Hertzer 4 stressed the ACAS conclusion in
which CEA was found to be statistically superior to
non operative treatment alone in the prevention of
subsequent stroke caused by asymptomatic 60–99%
ICA stenosis. To be effective the major complication
rate must be below 3%.
In our practice we usually follow the ACAS 3
guidelines and, on average, 30% of our CEAs are
performed on asymptomatic patients. Although our
patient was asymptomatic, re-intervention was rec-
ommended because of the severity of the restenosis
(90%). We performed a standard CEA without patch
interposition because the ICA diameter, evaluated
with an intra-operative caliper, was 8 mm.
Although several trials and a Cochrane review
attested that carotid patch angioplasty was the method
of choice especially in women, Counsell et al 5
concluded that there is limited evidence that carotid
patch angioplasty lowers the risk of perioperative
arterial occlusion and restenosis.
For this reason we adopt the primary closure
technique very rarely, especially in females, and only
if the ICA diameter is more than 7 mm. In routine
practice we usually employ the eversion technique for
small ICA, in females and where there is kinking of the
ICA. The results of this technique, as the EVEREST
trial 6 well shows, reports a restenosis rate comparable
to the patch angioplasty technique.
Carotid restenosis is one of the major factors
limiting long term patency following CEA. The real
incidence is unknown because it is strictly dependent
on the different methods of evaluation. The cumulat-
ive incidence has been reported by Lattimer et al. 7 to
range from 1 to 37% for the asymptomatic recurrent
stenosis and from 0 to 8% for the symptomatic one.
Myointimal hyperplasia represents the main aetiology
factor for early (,2 yrs) restenosis after CEA. It is
characterized by a concentric tubular thickening
extending along the intimal surface.
Fig. 1. IA DSA showing restenosis at one year.
Fig. 2. CAS: immediate result.
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The indication for primary re-operation is subject to
debate. Some reports recommended the surgical
approach only for severe symptomatic restenosis
whereas others suggested conservative management,
because of the benign natural course of these lesions.
For asymptomatic restenosis the indication for re-
operation is less clear because no randomized trials
have compared redo CEA with the best medical
treatment (BMT). The decision to treat asymptomatic
high grade restenosis is usually based on the fear of a
possible subsequent ICA occlusion.
Re-operation for severe restenosis is not free from
complications. In fact, cranial nerve damage and
neurological complications are more frequent than in
primary surgery .8,9 To minimize these problems,
endovascular treatment has been proposed as an
alternative to conventional surgery.
Endoluminal stenting 10,11 represents a reasonable
option for treating recurrent carotid stenosis especially
when the characteristics and the anatomical site of the
lesion can create situations less than ideal for
conventional surgery. New et al 11 suggest that carotid
stenting can be performed for ICA restenosis with a
complication rate similar to those of most published
studies on redo CEA. The occurrence of ipsilateral
secondary recurrent stenosis (SRCS) represents a
therapeutic dilemma.
The real incidence is unknown, Gagne et al. 12
report a rate of 21% of tertiary restenosis after redo
CEA. In the literature the incidence of stent restenosis
after carotid angioplasty and stenting (CAS) ranges
from 4 to 4.9% in a follow-up period between 6 and 12
months. .13 – 16 A recent report from Chakhtoura EY
et al. 17 reported 8% in-stent restenosis after a CAS
procedure.
Neointimal hyperplasia with smooth muscle cell
proliferation represents the main mechanism leading
to SRCS.. Rosenthal et al. 18 point out that this reaction
develops as an exuberant scar which may involve the
entire wall or may be localized at both the proximal
and distal end of the endarterectomy site.
In our case, severe myointimal hyperplasia was
identified at the proximal and distal ends of the carotid
stent and not at the level of the stent body. The stress
injury inflicted by the stent on the arterial wall
may have contributed to the development of SRCS
(Figure 3).
Several doubts still persist over the correct manage-
ment of this kind of case. Frequently, redo endarter-
ectomy is not technically feasible because a cleavage
plane cannot be established. Carotid patch angioplasty
and carotid resection with vein graft interposition
could be the options of choice. Rosenthal et al. 18
believe that resection with the interposition of a
saphenous vein graft is more durable than patch
angioplasty. Repeat angioplasty and restenting can
reasonably be carried out even though a high long
term incidence of intrastent restenosis is reported .19
In our case we proceeded first with stent removal
which was a simple procedure because the stent was
not incorporated in the arterial wall and then we
decided to perform a vein patch angioplasty because
Fig. 3. Secondary carotid restenosis within the stent.
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the luminal surface of the ICA was not too diseased. In
conclusion, to our knowledge, no report has addressed
the problem of restenosis after endovascular treatment
which requires another operation. Lack of long term
followup makes any procedure used in this situation
controversial We believe that prophylactic surgical
treatment could be considered for secondary recurrent
lesions that lead to a stenosis greater than 80%.
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